Innoviva, Inc. (INVA)
19.59
+0.08
(+0.41%)
USD |
NASDAQ |
Jan 14, 14:01
Innoviva Price: 19.59 for Jan. 14, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Amgen, Inc. | 326.89 |
| Eli Lilly & Co. | 1063.30 |
| Merck & Co., Inc. | 110.15 |
| Axsome Therapeutics, Inc. | 176.40 |
| Keros Therapeutics, Inc. | 19.43 |
Price Related Metrics
| PE Ratio | 14.05 |
| PS Ratio | 3.851 |
| PEG Ratio | 0.1370 |
| Price to Book Value | 1.450 |
| Price to Free Cash Flow | 7.883 |
| Earnings Yield | 7.12% |
| Market Cap | 1.465B |
| PEGY Ratio | 0.1370 |
| Operating PE Ratio | 9.227 |
| Normalized PE Ratio | 11.37 |